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ABBREVIATIONS 
AUB  : Abnormal uterine bleeding 
TVS  : Trans vaginal sonography 
SIS  : Saline infusion sonohysterography 
HPE  : Histo pathologic examination 
HYS  : Hysteroscopy 
GNRH : Gonadotropin Releasing Hormone 
FSH  : Follicle Stimulating Hormone 
LH  : Luteinizing Hormone 
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IGF  : Insulin like growth factor 
IGFBG : Insulin like growth factor binding globulin 
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INTRODUCTION 
 
Perimenopause or the recently preferred term „menopausal 
transition‟, is defined by WHO as the period in time beginning 2-8  years 
before the final menstrual period (FMP) and lasting up to 12 months after 
the FMP. The endocrinological, biological and clinical features of 
approaching menopause commence during this period
1
. The 
perimenopause is often characterized by irregularities in the menstrual 
cycle in volume and frequency. This is due to fluctuating estrogen levels. 
These changes are unique for each woman and are unpredictable. 
Although irregular bleeding patterns are normal and expected part of 
perimenopause, incidence of uterine pathology and associated medical 
complications increase in this age group
2
.  
 
 
Long anovulatory periods with unopposed estrogen stimulation 
may result in endometrial hyperplasia thus increasing the risk of 
endometrial cancers.Therefore, AUB in the perimenopausal age group 
assumes great significance. 
 
AUB is defined as bleeding that is excessive or occurs outside of 
normal cyclic menstruation. AUB is one of the most common complaints 
encountered in gynecology OPD and accounts to about 12% of 
consultations in any given gynecology OPD. It affects 20-30% of women 
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in the reproductive age group and up to 50% of the perimenopausal age 
group women. There is a lifetime chance of 1 in 20 for a woman to have 
menorrhagia
3
. 46-66 % of all hysterectomies are done for abnormal 
uterine bleeding. 
 
The diagnosis of AUB can be quite challenging, because of its 
broad range of differential diagnosis, in spite of detailed history, various 
blood tests, and a thorough examination involving transvaginal 
ultrasonography (TVS), the cause of bleeding is established in only 50 – 
60 % of the cases. 
 
The International Federation of Gynecology and Obstetrics, 
working group on menstrual disorders has recently developed a 
classification system (PALM – COEIN) for the cause of AUB in non – 
gravid women of reproductive age group. There are nine main categories, 
which are arranged accordingto the acronym PALM – COEIN, polyp, 
adenomyosis, leiomyoma, malignancy and hyperplasia, coagulopathy, 
ovulatory dysfunction, endometrial, iatrogenic and not yet classified
4
. 
According to the proposed classification system, non-specific terms like 
dysfunctional uterine bleeding should be abandoned to favour more 
specific terminology like ovulatory dysfunction. 
  
15 
 
 
Besides systemic, iatrogenic or hormonal age related causes, an 
endometrial pathology (polyps, submucous myomas, endometrial 
hyperplasia and endometrial carcinoma)must alwaysbe suspected. 
Infectious endometritis can also be a cause. Diagnosis and treatment of 
endometrial pathology can nowadays benefit from well – established 
techniques, ranging from clinical examination to transvaginal sonography 
(TVS), saline infusion sonohysterography (SIS) hysterosalpingography, 
hysteroscopy (HYS) and endometrial biopsy
5
. 
 
 
  
16 
 
AIMS AND OBJECTIVES 
1. To evaluate the endometrium in perimenopausal womenpresenting 
with abnormal uterine bleeding using transvaginal sonography and 
saline infusion sonohysterography. 
2. To compare and correlate transvaginal sonography and saline 
infusion sonohysterography with histopathological examination 
and hysterectomy findings. 
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REVIEW OF LITERATURE 
 
Any bleeding outside the specified normal limits is termed as 
abnormal uterine bleeding. In perimenopausal age group anovulatory 
AUB is more common, but endometrial pathology especially endometrial 
malignancy must always be ruled out. 
 
The female reproductive system involves intricate balance and 
interaction of many components for the normal menstrual cycle to occur. 
This involves the central nervous system, the pituitary glands, the ovary, 
and the outflow tract including the endometrium. 
 
Hypothalamo – Pituitary Axis 
The two major sites for the regulation of menstruation are the 
hypothalamus and the anterior pituitary. The hypothalamus is situated at 
the base of the brain below the 3
rd
 ventricle and above the optic chiasma. 
It is connected to several areas of the brain like pituitary 
gland,hippocampus,pons, amygdala and the thalamus. The hypothalamus 
secretes various hormones including gonadotrophin releasing hormone 
(GNRH). These hormones are taken to the pituitary by the 
hypothalamohypophyseal portal system. Several feedback loops exist in 
the hypothalamus. They can be ultrashort loops existing within the 
18 
 
hypothalamus, short loops between the pituitary and the hypothalamus or 
long loops by estrogen and progesterone
6
 
Hypothalamus also secrete dopamine which is the inhibitor of 
prolactin. The hypothalamo-pituitary axis is not fully developed until 
puberty, becomes gradually sensitive and become fully established by 13 
– 14 years. 
 
FSH and LH secreted by the pituitary is controlled by GNRH by 
feedback mechanism. GNRH is secreted by the arcuate nucleus of the 
hypothalamus in a pulsatile manner. The frequency and amplitude of the 
GNRH pulses differ for FSH and LH secretion. The GAP (GNRH 
associated peptide) is a potent stimulator for FSH and LH and inhibitor of 
prolactin secretion
7
. 
 
Pituitary Gland 
The pituitary by itself has two lobes the anterior and posterior 
lobes, which are anatomically and embryologically different. The anterior 
lobe is derived from the Rathke‟s pouch and the posterior lobe is an 
extension of the hypothalamus and shares portal blood vessels with it. 
 
Both FSH (follicle stimulating hormone) and LH (luteinizing 
hormone) secreted by the anterior pituitary share a common ὰ  subunit 
and have different β subunits. 
19 
 
 
The follicle stimulating hormone is a glycoprotein which is 
stimulated by the GNRH production and suppressed by estrogen and 
inhibin.It has two peak levels in the menstrual cycle, one on the 6
th
 day of 
the follicular phase and the second one at the 12
th
 day just before 
ovulation. It mainly helps in the recruitment of follicles and aids in 
follicular growth.It also acts on the granulosa cells and causes increase in 
their number, increase in aromatase inhibitor and LH receptors. 
LH production is stimulated by high levels of estrogen and GNRH 
and suppressed by moderate level of estrogen. It has a peak 24-36 hours 
before ovulation
5
. The functions of LH are many, it mainly triggers 
ovulation, causes stimulation of androgen production by theca cells and 
stimulates the synthesis of progesterone by corpus luteum. 
Ovary 
The ovaries are the paired gonads that consist of cortex and 
medulla. They are responsible for production of the steroid hormones 
estrogen and progesterone.  Estrogen is produced by the granulosa cells 
of the Graafian follicle and progesterone is produced by the theca cells of 
corpus luteum. Small amount of estrogen is also produced by adipose 
tissue. Estrogen triggers LH surge and inhibits FSH. Progesterone reaches 
its peak level in the luteal phase and it mainly prepares the endometrium 
for implantation, if any fertilization takes place. 
20 
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Regulation of the Menstrual Cycle 
The menstrual cycle includes two cycles – the ovarian cycle and 
the uterine cycle. The ovarian cycle has two phases- the follicular and the 
luteal phase. The uterine cycle has two phases- the proliferative and the 
secretory phase. 
 
Follicular Phase  
 
It is the phase during which follicular development occurs in four 
stages from the primordial follicle into the fully developed Graffian 
follicle. The primordial follicle is a single layer of flattened granulosa 
cells. Next stage is the primary follicle. 
 
The primary follicle is the one in which the granulosa cells are 
lined by cuboidal epithelium and undergo pseudo stratification. Also 
there is an increase in the number of cells resulting in the formation of 
zona pellucida. From the primary follicle, arises the secondary follicle. 
 
The secondary follicle also known as the preantral follicle consists 
of the granulosa cells surrounded by theca interna and theca externa. The 
stroma surrounding the granulosa cells undergoes differentiation into the 
theca cells. There is a collection of fluid in the follicle and between the 
granulose cells, as the FSH levels increases
8
. This is called an antrum. 
Only 4-5 follicles attain this stage in each cycle. When the FSH levels 
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declines, one follicle which has high number of TSH receptors continue 
to grow as a GraFffian follicle.  
The Graafian follicle consists of mural granulosa, which are the 
cells around the antrum and the cells surrounding the oocyte is called the 
corona radiata. Cumulus oophorus is the mass of cells formed by the 
ovum and the granulosa cells
9
 . 
 
Ovulation  
Ovulation is the process of expulsion of the ovum. It is triggered by 
the LH surge. During this stage, there is extrusion of the polar body and 
the first meiotic division of the oocyte is completed
10
. 
 
Luteal Phase  
It consists of the formation of the corpus luteum to the onset of 
menses, which is usually constant at about 14 days. Once the ovulation is 
completed, the left-over Graafian follicle undergoes luteinisation. 
Luteinisation is the deposition of lipids and lutein pigment to become 
corpus luteum. The corpus luteum secretes high amounts of progesterone, 
estrogen and inhibin A. Neovascularisation of the corpus luteum occurs 
and the hormones enter the general circulation. If fertilisation does not 
occur, the corpus luteum degenerates, a process known as luteolysis
11
 and 
becomes corpus albicans. 
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Anatomy and Histology of Normal Endometrium 
 The endometrium is divided into superficial functional layer and 
deep basal layer.The functional layer is very sensitive to estrogen and 
progesterone and undergoes cyclical changes according to the phase of 
menstrual cycle. The basal layer does not undergo changes and serves as 
a source for endometrial regeneration
12
.  
 
The superficial layer (two - third) 
 Stratum functionalis 
 Consists of two zones 
o Superficial – stratum compactum composed of glands and 
stroma. 
o Deep – stratum spongiosumcontaining endometrial glands, 
increased interstitial tissue and less stroma. 
 
The deep layer (one-third) 
 Stratum basalis which is formed by a single layer of cuboidal 
epithelium which dips into form tubular glands. 
 
Uterine Cycle 
Proliferative Phase 
Day 1 is the start of the vaginal bleeding. The endometrium is seen 
as a thin echogenic line on completion of menses. The entire stratum 
24 
 
compactum and a part of stratum spongiosum get sloughed off with the 
menses.The basale layer does not slough. After menses there is only 
stratum basale and few part of stratum spongiosum. Estrogen increases 
and causes stimulation of endometrial glands and proliferation of stroma 
and thickening of stratum functionale
13
. 
 
By mid-follicular phase on ultrasound a trilaminar phase of the 
endometrium is seen and the thickness increases from 1-2 mm to about 6 
mm on day 7 and the endometrium thickens further and is usually 8 mm 
before ovulation. The endometrial glands increase in tortuosity and the 
stromal and mitotic figures increase in number. There is alsopseudo 
stratification of the cells lining the glandular epithelium. 
 
Follicular Phase Histopathology 
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Decretory Phase 
Progesterone is the hormone responsible for secretory phase and 
the increasing progesterone level cause significant endometrial changes. 
Glycogen-rich sub nuclear vacuolation appears at the base of the 
glandular cells which is the first appearance
14
. After ovulation the 
trilaminar appearance is lost and there is increased and uniform 
echogenicity of the endometrium. The mean endometrial thickness is 12 
mm. The endometrium is vascularised and causes supercoiling of spiral 
arterioles that secrete clear fluid. The length of the cycle is constant, 
about 14 days. 
 
Towards the end of the secretory phase the glands become more 
tortuous and the stroma becomes vascular. If implantation does not take 
place the glands collapse and the neutrophils and the leukocytes begin to 
infiltrate to produce inflammatory cytokines. The MMPs Matrix metallo-
proteinases)  like collagenases also increase. As a result this causes 
release of various enzymatic substances and disruption of the 
endometrium and tissue necrosis. The theory is that this oestrogen – 
progesterone withdrawal results in degradation of the functionalis layer. 
This hormonal withdrawal causes release of lysosomal enzymes that 
activates inflammatory proteases and proteolytic MMP‟s. All these lead 
to endometrial sloughing.  
26 
 
 
 Vasoconstriction is also mediated by endothelin and PGF2α. 
Regeneration usually begins after 36 hours of menses. Regeneration 
occurs from epithelial out growths of the basal glands. Bleeding stops 
generally with complete reepithelialisation of the endometrium usually by 
day 5. 
 Secretory Phase Histopathology 
 
 
 
Menstruation 
The corpus luteum degenerates if fertilization does not occur. 
There is sudden withdrawal of both oestrogen and progesterone. As a 
result, the secretory changes in endometrium are brought to a halt. The 
superficial endometrium loses its blood supply and necrosis occurs. 
Release of prostaglandins causes dysmenorrhoea. Foci of necrosis appear 
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in endometrium and they coalesce. Degeneration of vessel walls occur 
and menses is initiated. Menstrual blood contains mainly arterial blood, 
tissue debris, prostaglandins, and lots of fibrinolysins. The duration of 
menses is usually about 3 – 5 days. Blood loss beyond 80ml is considered 
abnormal. 
 
Risk Factors for Premalignant and Malignant Conditions of the 
Endometrium  
 
The average age for women with endometrial cancer is 61 years, but 
5% to 30% of cases can occur in premenopausal women. Women under 
the age of 50 share many of the risk factors for endometrial cancer of 
older women including obesity, nulliparity, history of PCOS, Diabetes  
and family history of Hereditary Non-Polyposis Colorectal Cancer. 
Women with HPNCC have a lifetime risk of 40% to 60% for endometrial 
cancer and colorectal cancer and 12% for ovarian cancer. 51% had 
endometrial cancer diagnosed at a mean age of 44.  
 
Therefore we should be aware that younger women with a diagnosis 
of cancer endometrium may be at greater risk of colon and ovarian 
cancer. Women with irregular bleeding and a history of obesity, 
polycystic ovarian syndrome, nulliparity and diabetes, and a history of 
HPNCC are at higher risk for premenopausal endometrial cancer. 
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Younger women with the above risk factors should always be triaged for 
endometrial assessment. 
 
Evaluation of Endometrium: 
As a cause of AUB, endometrial evaluation is done by mainly three 
modalities 
 Imaging modalities that includes transvaginal ultrasonography 
(TVS), hysterosonography, magnetic resonance imaging (MRI) 
and colour Doppler. 
 Visually by hysteroscopy. 
 Cellular assessment of endometrial samples by microscopic 
evaluation. 
Imaging Modalities: 
Transvaginal ultrasonography 
TVS is a non – invasive, cheap and convenient way to visualize the 
cavity of the endometrium. It is therefore the first line tool for diagnosis 
and assessment of the uterine pathology in reproductive age women. The 
edometrium in reproductive age group varies from 2 mm in earlier 
follicular phase to 6 mm in late luteal phase.  
 
The endometrial thickness is measured and represented as the sum 
of two adjacent layers of endometrium, a measurement called the 
Endometrial Echo Complex (EEC), as a maximal double layer thickness 
29 
 
in mid-sagittal section at the thickest area of the endometrial near the 
fundus, including the outermost border of both sides of the endometrium. 
 
 
Saline Infusion Sonohysterography (SIS)  
In 1993, Journal of Clinical Ultrasound termed the technique 
„sonohysterography‟15. It is a transcervical introduction of fluid. It 
provides enhanced endometrial visualization. The examination is usually 
scheduled between day 5 to 10 of menstrual cycle. 
 
 
Under strict aseptic precautions, 5F Foley‟s catheter is inserted. 
Balloon is filled and snug against the internal OS. Speculum is removed, 
10ml syringe is attached with sterile saline in it. TVS probe is inserted. 
 
Fluid is instilled while the probe is subjected to each cornual region 
along the long axis plane. Probe is turned 90 degree and more fluid is 
instilled in the viewed plane. SIS helps to see if there is any thickening of 
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the endometrium of the uterus, or if there are polyps.  Polyps are small 
growths of the endometrium.  The scan can also be performed in the 
assessment of post-menopausal endometrium or possible Asherman‟s 
Syndrome (a condition caused by the presence of scars in the uterine 
cavity). The entire procedure usually takes about 30 minutes. Most of this 
time is occupied by scanning before and after the saline is put into the 
uterus. The actual time taken for the saline to be put in is only 2-3 
minutes. 
SIS Image 
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Indications of SIS
16
 
 Abnormal uterine bleeding  
 Endometrial thickness >5 mm in postmenopausal women and 
endometrial thickness > 8 mm in premenopausal women with 
irregular bleeding,heavy or prolonged periods 
 Cystic and echogenic or heterogeneous endometrium on 
ultrasound. 
 Hyperechoic line around theendometrium. 
 Failure to visualise endometrium on ultrasound 
 Recurrent  pregnancy loss 
 Amenorrhea/oligomenorrhea 
 Before assisted conception 
Advantages of SIS 
 Reliable in detecting polyp, fibroid, focal endometrial thickening, 
as well as septae and adhesions. 
 Outpatient procedure 
 Does not cause significant pain 
 Cost effective 
 Delineates sub-endometrial thickening in patients on Tamoxifen. 
 Outpatient approach to bleeding, infertility and Recurrent 
pregnancy loss. 
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Risks and complications of SIS 
SHG is a very safe procedure and usually is performed without any 
incident. Serious complications are rare. The most common serious 
complication with SHG is pelvic infection. However, this occurs less than 
1% of the time and usually occurs when a woman also has a block or 
infection of the fallopian tubes. 
 
Normal findings in SIS  
The procedure is done in the proliferative phase when the 
endometrium is thinnest for the easy detection of polyps. Normal 
endometrium should be distended in a symmetrical fashion and is well 
demarcated and is surrounded by anechoic saline. Fluid in the pouch of 
Douglas indicates patent fallopian tubes.  
 
Abnormal findings of SIS 
 
1. Polyp – it appears as protrusions into the cavity,intrauterine local 
overgrowth , echogenicity is hyperechoic as compared to the 
myometrium but similar to the endometrium and connected to the 
endometrial wall by a stalk or forms acute angle with the 
endometrial lining
17
. 
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2. Intracavitary and submucous fibroids – they appear as filling 
defects with mixed echogenicity, heterogeneous echotexture , 
hypoechoic relative to the myometrium with the broad base and it 
forms right or obtuse angle to the endometrial lining. Extension of 
the fibroids up to the serosal surface of the uterus is noted as the 
resection of the fibroids should not be attempted in such patients. 
 
3. Endometrial thickness – thickest part between the basal layers of 
both anterior and posterior walls. Homogenous, heterogeneous and 
cystic differentiation of the texture in the endometrium. 
Pathological TVS or SIS shows double layered endometrial 
thickness > 5mm or the presence of polyp or a fibroid
17, 18
. 
 
4. Focal endometrial thickening - Endometrial thickness of anterior 
and posterior wall is measured separately identifying focal 
thickening. This helps and guides biopsy at hysteroscopy. 
Irregularities in the surface of the endometrium,heterogeneity of 
the endometrium, irregularities of the junction between the 
endometrium and myometrium and uniform increased echo texture 
of the endometrium raise the suspicion of a malignancy. 
 
5. Abnormalities of uterine cavity- Intrauterine adhesions and 
malformations of the uterine cavity appears as immobile 
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connections between the anterior and posterior wall. The adhesions 
are usually thick and widespread and distention of the cavity will 
be difficult. Incomplete separations of the uterine walls, denotes 
intrauterine synechiae and the uterus appears as a bow – tie 
appearance on transverse sections. Malformations of the cavity will 
be seen as much thicker connections between each walls. 
 
Differentiation of SIS findings 
 
 
Endometrial polyps 
 
 
Submucous myomas 
 
Echogenic 
 
 
Hypoechoic 
 
It projects into the endometrial 
cavity 
 
 
It distends the uterine lumen 
 
Stalk can be identified 
 
The base is broad 
 
 
Polyp stands out more relative to 
hypoechoic myometrium 
 
 
Best delineated against echogenic 
endometrium 
 
May demonstrate vascular pedicle 
on Doppler 
 
 
Demonstrates peripheral vessels 
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Magnetic resonance imaging (MRI) 
It is recently gaining popularity worldwide in the evaluation of 
women with abnormal uterine bleeding. T weighted images are 
constructed by sending radio frequency pulses to the tissues within the 
magnetic field and images are obtained in multiple planes in thin slices. It 
helps us in clearly delineating fibroid and adenomyosis, helps calculating 
the distance from the uterine cavity and also gives the perfect anatomy of 
the uterus
18
.MRI guided FUS (focussed ultrasound surgery) is also used 
to treat myomas. 
 
Colour Doppler technology  
By Doppler technology, blood flow to organs can be measured.  It 
displays the blood flow in blue and red. Red denotes blood flow towards 
the transducer and blue denotes blood flow away from the transducer. 
The pulsatility index and the resistance index are most commonly used. 
 
The resistance index is low (<0.4) when there is increased blood 
flow as in malignancy, fibroids and in ovarian torsion where there is 
impedance of flow. 
 
Hysteroscopy: 
Hysteroscopy is considered as the gold standard approach for the 
most accurate evaluation of the endometrium. The procedure should be 
36 
 
done in early proliferative phase. A single stop approach, especially in 
high risk women [diabetes, obesity, H/O endometrial, ovarian, breast 
cancer in the family members, women with endometrial hyperplasia (> 4 
mm postmenopausal and > 12 mm premenopausal AUB)], it is the most 
accurate and minimally invasive approach in current day practice
19
. 
 
Hysteroscopy helps in the direct visualization of the endometrial 
lining and intrauterine pathology like polyps, myoma, hyperplasia, and 
carcinoma. It has better diagnostic yield. Directed biopsy is possible and 
many benign lesions like polyps, small myomas can be treated in the 
same sitting. 
Hysteroscopy is the inspection of uterine cavity by an endoscopy 
accessing through transvaginal approach. It is introduced in a sheath that 
provides an inflow and outflow channel for insufflations into the uterine 
cavity. In addition to that, an operative channel is needed to introduce 
scissors, graspers, and instruments. The distention media used is glycine. 
A contact hysteroscope is one that does not use distension media. 
 
A paracervical block may be used and the patient is placed in 
lithotomy position during the procedure. Misoprostol can be used prior to 
the procedure as it aids in easy dilatation of the cervix. Prophylactic 
antibiotics are not necessary for the procedure. 
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It is considered as the definitive diagnosis and also the treatment of 
symptomatic intrauterine pathology, but it is the most invasive and 
costlier method of all modalities available. Due to emerging modern 
operative equipment, using hysteroscopes with a smaller diameter of 2 – 
3 mm allows the gynaecologists to perform the procedure with minimal 
anaesthetic requirements and in a day-care setting. With experienced and 
trained hands, the incidence of the complications like uterine perforation, 
infection and bleeding are very minimal.  
 
The indications are in Asherman‟s syndrome where hysteroscopic 
adhesiolysis can be done, polypectomy in case of endometrial polyp, 
endometrial ablation, myomectomy for uterine fibroids, in diagnosing and 
treating endometrial ablation, removal of embedded IUDs and in selected 
patients‟ removal of retained products of conception. 
 
Complications include perforation, Peritonitis, cervical lacerations, 
and complications of using distension media like electrolyte imbalance. 
 
Endometrial sampling: 
In women with abnormal uterine bleeding, endometrial sampling 
can be both therapeutic and diagnostic. It is a simple office based OPD 
procedure and helps us in diagnosing tuberculosis, malignancy, 
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hyperplasia and confirmation of ovulation.Sampling can be obtained 
either by brush, cannula or a curette. 
 
Pipelle, which is a cannula can also be used to aspirate endometrial 
tissue while performing examination of the patients. It is about 3-4 mm in 
diameter and can be introduced into the cervical os which can be 
performed even in postmenopausal age group women who have stenosed 
os.  
 
After informed consent, the patient is placed in dorsal lithotomy 
position, using povidone iodine solution, local parts are cleaned, Sims 
bivalve speculum is introduced, the posterior vaginal wall is retracted and 
the cervix is brought to view. The anterior lip of cervix is held by 
vulsellum and the cannula is inserted through the os into the uterine 
cavity to scrape the endometrial tissue. It is fixed with 10% formalin and 
sent for histopathological examination. It has quite a good yield as to that 
of the standard methods. But curettage is now recognised as a blind 
sampling technique and should no longer performed separately with 
limited exceptions
20
. 
  
39 
 
Clinical terminology used in abnormal uterine bleeding 
 Normal  
The normal menstrual bleeding is that having regular frequency 
which is normal in amount and duration with the cycles between 21 – 35 
days. 
  
Menorrhagia  
Menorrhagia is prolonged or heavy cyclical bleeding which may 
excessive in amount or the number of days more than the normal flow . 
The cycle is not altered and the duration is more than 7 days or the blood 
loss is usually more than 80 ml .  
 
Hypomenorrhea 
Hypomenorrhea is defined as the normal regular cycles , but scanty 
in amount and duration . The causes includes endometrial problems like 
Asherman‟s syndrome  and Genital Tuberculosis . 
 
Polymenorrhea 
Polymenorrhea is defined as shortened cycles  less than 21 days but 
the cycles are of  normal frequency and the flow is normal in amount and 
duration. It is usually seen in Inflammatory conditions of the ovaries like 
Indometriosis and Pelvic Inflammatory Diseases. 
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Oligomenorrhea  
Oligomenorrhea is defined as the reduction in the frequency of the  
menstrual cycles with the intervals between the cycles varying between 6 
weeks to sometimes 6 months .Hormonal  dysfunctions like PCOS , 
hyperprolatinomas  and hypothyroidism are the important causes .These 
are usually anovulatory cycles . 
 
Metrorrhagia 
Metrorrhagia is defined as menstrual bleeding occurring in 
between normal cycles . cervical polyp , endometrial polyp and the local 
lesions are the most common causes presenting with metrorrhagia. 
Hormonal therapy can also be a cause . 
 
Menometrorrhagia 
Menometrorrhagia is having menstrual cycles irregularly with no 
common pattern but the flow is increased in amount and duration . In 
general , Regular bleeding is likely to be due to organic problems and 
irregular bleeding is mainly due to ovulatory dysfunction and is usually 
due to dysfunctional uterine bleeding . 
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Pathological lesions causing abnormal uterine bleeding: 
Endometrial hyperplasia 
Endometrial hyperplasia is due to unopposed, continuous 
estrogenic stimulation in the absence of the progesteronic effect. It is 
important to identify as it may present as abnormal uterine bleeding but 
unfortunately it precedes or occur in synchrony with cancer endometrium. 
 
WHO classification
21
 
 
Type of hyperplasia 
 
 
Progression to cancer 
 
Simple hyperplasia 
 
1% 
 
 
Complex hyperplasia 
 
3% 
 
 
Simple hyperplasia with atypia 
 
8% 
 
 
Complex hyperplasia with atypia 
 
29% 
 
 
In simple hyperplasia, the endometrium is markedly thickened and 
there is increased glandular to stromal ratio but no crowding of glands 
and no cytological atypia.  
In complex hyperplasia, histologically, the endometrium shows 
budding and infolding of the glands with crowded glands and without 
atypia. 
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In atypical hyperplasia, there will be cytological atypia in which 
the cells shows loss of polarity, increased nuclear cytoplasmic ratio, 
prominent nucleoli, clumped chromatin and large nuclei of varying size 
and shape and it can be simple or complex depending upon the 
architecture of the glands. 
 
Endometrial polyps 
Endometrial polyps are localized hyperplastic overgrowths of the 
endometrial glands and the stroma which form projections from the 
surface of the endometrium. It can be asymptomatic, or may present as 
menorrhagia, postmenopausal bleeding, prolapse through the cervical os, 
abnormal vaginal bleeding or breakthrough bleeding during hormonal 
therapy. 
 
The risk factors for the endometrial polyps are 
 Hormonal replacement therapy 
 Tamoxifen therapy22 
 Diabetes  
 Hypertension 
 Obesity 
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Tamoxifen and the Uterus 
Tamoxifen is a Selective Estrogen Receptor Modulator (SERM) .  
It is used as a adjuvant in the treatment of breast cancer which has 
estrogen positive receptors . 
 
It has negative effect on breast in which it diminishes oestrogen 
action in the breast but has positive effect on the uterus causing 
endometrial proliferation. It can cause Endometrial hyperplasia, 
Endometrial polyp, carcinoma and sometime sarcomas .  
 
Screening   
Screening women who is on Tamoxifen and who do not have any 
abnormal bleeding  is proved to be ineffective . Women who use 
Tamoxifen should undergo evaluation only when bleeding develops. 
Several protocols have failed to identify endometrial cancer in 
asymptomatic women. 
 
The normal tamoxifen mediated endometrial changes are the following : 
1. Irregular , cystic and thickened endometrium . 
2. Cystic changes in the subendometrial region without causing 
epithelial disease . 
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Classification of abnormal uterine bleeding
23
 : 
 
Abnormal uterine bleeding is of two types: 
 Anovulatory (80%) and includes 
o Metropathia haemorrhagica 
o Threshold bleeding  
 
 Ovulatory (20%) and includes 
o Idiopathic ovulatory menorrhagia 
o Luteal phase defect 
 
Anovulatory bleeding 
Metropathia haemorrhagica 
It is known that the LH surge in mid-cycle triggers ovulation. In 
the perimenopausal age group, the ovarian follicles do not grow into the 
dominant follicle and this leads to the lack of ovulation. Hence in the 
presence of unopposed estrogen the endometrial proliferation occurs 
followed by profuse, painless, prolonged bleeding that may continue to 
even 30 days. 
 
The endometrium is usually associated with cystic, hyperplastic 
and irregularly dilated glands, tortuous, dilated and thin walled spiral 
arteries with thrombi formation and also associated with increase in 
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vascularisation. The superficial endometrium undergoes necrosis and the 
histopathological examination shows the typical „Swiss cheese pattern‟ 
appearance. 
 
Threshold bleeding 
This is seen in perimenopausal woman due to insufficient follicular 
development leading to the low levels of estrogen and almost no 
progesterone for the endometrium to grow. The patients present with 
polymenorrhagia and profuse bleeding due to the lack of prostaglandin 
production PGF2α. 
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PATHOPHYSIOLOGY OF ANOVULATORY BLEEDING 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Metropathia Hemorrhagica Threshold Bleeding 
Prolonged Estrogen 
No progesterone 
Low Estrogen  
No progesterone 
↓ PGF2α 
 
↓ PGF2α 
Amenorrhea followed by 
bleeding 
Polymenorrhea 
Hyperplastic Endometrium Proliferative endometrium 
Anovulatory bleeding 
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Ovulatory bleeding 
It accounts for 20% of the DUB and is common in reproductive 
age group. It is associated with cyclical abdominal pain with bleeding or 
premenstrual spotting. 
 
Idiopathic ovulatory menorrhagia 
This is due to abnormality in the ratio of PGE and PGF2α in the 
endometrium leading to increase in PGE and reduction of thromboxane 
production in the endometrium, also increased activity of the fibrinolytic 
pathway is established. Since ovulation and production of progesterone 
occurs, the bleeding is painful. PG synthetase inhibitors and anti-
fibrinolytics are effective in this type of bleeding. 
 
Luteal phase defect 
It occurs due to inadequate functioning of the corpus luteum. Due 
to alteration in prostaglandins and insufficient production of 
progesterone, spotting occurs 5 – 6 days prior to the onset of normal 
menstrual cycle. Histological examination reveals irregular and patchy 
secretory changes referred to as irregular ripening.  
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PATHOPHYSIOLOGY OF OVULATORY BLEEDING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Idiopathic ovulatory 
menorrhagia 
 
Corpus luteal 
insufficiency 
 
 
Normal progesterone 
 
 
↓ Progesterone 
 
Altered PGE2: PGF2α 
 
↓ PGF2α 
 
Mennorhagia 
 
Premenstrual spotting 
(polymenorrhea) 
 
Secretory Endometrium 
 
Irregular ripening 
 
Ovulatory bleeding 
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Estrogen withdrawal bleeding 
Bleeding that occurs due to sudden withdrawal of estrogen 
hormone. This can occur when bilateral oophorectomy is done in the 
follicular phase or a midcycle bleed that occurs before ovulation due to 
sudden, transient decrease in the estrogen levels. 
 
Estrogen breakthrough bleeding 
In anovulatory cycles due to continuous estrogen exposure 
bleeding may sometimes occur, known as estrogen breakthrough 
bleeding. It depends on the amount and duration of the unopposed 
estrogen exposure. Low levels of the chronic estrogen exposure causes 
intermittent staining or spotting, which is prolonged but very minimal in 
volume. 
 
Continuous high levels of estrogen in long period of amenorrhoea 
results in acute episode of profuse bleeding that varyboth in amount and 
duration. 
 
Progesterone withdrawal bleeding 
Bleeding occurs when treatment with exogenous progesterone or 
synthetic progesterone is stopped. It always occurs in the endometrium 
primed by the estrogen. The amount and duration of bleeding varies and 
generally correlates with level and duration of the endometrial 
50 
 
proliferation stimulated by estrogen. Bleeding can be similar as to that of 
normal menstrual cycle. 
 
Progesterone breakthrough bleeding 
Bleeding occurs when the amount of progesterone is very high as 
compared to that of the estrogen. It results in intermittent bleeding of 
varying duration and is light in amount. 
 
Pathophysiology of anovulatory bleeding 
Due to the constant unopposed estrogen stimulation, the 
endometrium is overgrown and structurally becomes fragile due to the 
lack of stability and stromal support given by progesterone. Persistent 
hyperplastic and proliferative endometrium contains numerous discrete 
focus of stromal breakdown, associated with extravasated RBCs, thrombi 
containing platelets and fibrin recognised as ball of aggregates below the 
intact epithelium
24
.Capillaries are increased and dilated and have irregular 
and abnormal channels that also contribute to fragility.  
 
The release of proteolytic enzymes and migratory leucocytes and 
macrophages causes the fragile and irregular endometrium to bleed. This 
is further aggravated by local release of the prostaglandins PGE2 and 
PGF2α. Vascular constriction does not occur in the normal way because 
tissue loss is only focal and superficial and does not reach the basal layer 
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when vasospasm response is intense. The epithelial reconstruction also 
occurs but not in a normal fashion. Epithelial repair is focal and not 
universal, thereby a constantly changing patchy work occurs in the 
endometrium instead of well-structured and well organised remodelling
25
 
 
The PALM – COIEN Classification 
 
It is the classification for the causes of abnormal uterine bleeding 
in perimenopausal age group. 
 
It has 9 categories as follows: 
P: polyp 
A: adenomyosis 
L: leiomyoma 
M: malignancies and hyperplasia 
C: coagulopathy 
O: ovulatory disorders 
E: endometrial causes  
I: iatrogenic 
N: Not yet classified 
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Polyps (AUB _ P) 
Polyps are again classified as present or absent and are diagnosed 
by ultrasound / saline infusion sonohysterography / histology / 
hysteroscopy or a combination of these investigatory modalities. 
 
 
Adenomyosis (AUB _ A) 
For assigning women in this group, sonographic criterion is 
considered essential for the diagnosis. Histopathological examination or 
MRI is not essential for the diagnosis. 
 
Leiomyoma (AUB _ L) 
Leiomyoma is classified under two categories, primary or 
secondary system. 
In primary classification, presence or absence of leiomyoma is 
noted. It needs only sonographic evaluation and it is irrespective of the 
number, location or size. 
In secondary system they are distinguished as those involving 
endometrial cavity [submucosal (SM)] from others. 
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Classification system of Leiomyoma 
 
SM- Submucosal                                             
Type 0-Pedunculated intracavitary     
 Type 1-<50% intramural      
 Type 2->50% intramural 
O-other         
 Type 3- contacts endometrium, 100% intramural  
 Type 4- Intramural       
 Type 5- subserosal >50% intramural    
 Type 6- subserosal <50% intramural    
 Type 7- subserosal pedunculated     
 Type 8- Others (e.g., cervical, parasitic) 
Malignancy and hyperplasia (AUB-M): 
 It is more common in conditions where there is unopposed 
estrogen acting in the endometrium like chronic anovulation and PCOS. 
They are in the process of evaluation and are further classified under 
FIGO classification of malignancies. 
 
Coagulopathy (AUB_C) 
The most common causes for bleeding in this category is Von 
Willebrand factor deficiency. Nearly 13 % of such women have heavy 
menstrual bleeding. 
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Ovulatory disorders (AUB _ O) 
  A few important causes of ovulatory dysfunctions are 
hypothyroidism , hyperprolactinomas , stress , obesity , excessive weight 
loss , polycystic ovarian syndrome and also certain drugs acting on the 
hypothalamo – pituitary axis like tricyclic antidepressants , 
phenothiazines, etc., and dysfunctions noted in the extremes of 
reproductive age group including menopausal transition. 
 
Endometrial disorders (AUB _ E) 
The primary disorders of the endometrium are those affecting the 
mechanisms of endometrial haemostasis. It may be due to the deficiency 
of locally acting vasoconstrictors like PGF2α and endothelin I or may be 
due to excessive production of plasminogen activator. 
 
Iatrogenic (AUB _ I) 
The causes may include intrauterine contraceptive devices, use of 
gonadal steroids and the drugs affecting the metabolism of dopamine or 
drugs affecting the hypothalamo – pituitary axis. 
 
Not Yet Classified (AUB _ N) 
It includes rare causes like endometritis, AV malformation and 
hyperplasia of the myometrium.  
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Evaluation of AUB in Perimenopausal  Age 
 
            
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Abnormal Uterine Bleeding In Perimenopausal  Age 
Group 
 
 
 
Clinical Evaluation 
 
Transvaginal Ultrasound 
Endometrial Biopsy and Sampling 
Complex or Atypical  
Hyperplasia 
 
Proliferative or Simple 
Hyperplasia 
 
Progesterone Hysterectomy 
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Progesterone  
Progesterones like Medroxy progesterone , Norethistrone and 
norethynodrel are the most commonly used progestogens are used to 
areest the bleeding and also to regulate the menstrual cycle . 
 
To arrest profuse bleeding , they are used in a dose of 10 mg 6 th 
hourly for 1 – 2 days till bleeding stops and then gradually reduced to 10 
mg thrice , and then 10 mg twice a day and then daily 10 mg once daily 
for 21 days . 
 
Cyclical progesterones  can be used in 5 – 10 mg daily from day 15 to 
day 25 of the menstrual cycle in Luteal Phase Defect . In patients with 
simple hyperplasia , the dose is 10 mg daily from day 5 to day 25 of the 
menstrual cycle . 
 
LNG – IUS 26 
It is a T shaped intra uterine device containing 52 mg of  
levonorgesterel and releases 20 microgram / day . It is commonly called 
as Mirena . 
 
LNG IUS have hemostatic effect on the endometrium by 
antogonising the proliferation caused by estrogen hormone . It causes 
thrombosis of the spiral arteries in the endometrium . It increases the 
IGFBP – 1 , which binds to IGF – 1 and suppresses endometrial IGF – 1 
that have promoted  endometrial mitoses. 
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It is concentrated 3000 times more in the uterus than in blood and 
the endometrial proliferative inhibitory effect is 8 years whereas the 
contraceptive effect is only 5 years. The reduction in menstrual blood loss 
is with LNG – IUS is nearly  94 % . 
 
Hysterectomy  
The advantages are  
1. It is the most effective treatment for controlling  the bleeding  
2. The satisfaction rates are nearly 80 % 
3. Subjective improvement in dysmenorrheal and premenstrual 
symptoms are noted . 
 
The disadvantages are  
1. Complications in the peri operative period including bladder and 
bowel injuries  
2. Costs, operative time , hospitalization and the recovery time  are  
more as when compared to the medical management . 
3. In nearly 1/3 rd of the cases , normal uterus is removed . 
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MATERIALS AND METHODS 
Study Design: 
Prospective descriptive study 
 
Study population: 
Perimenopausal woman with abnormal uterine bleeding attending 
gynaecological OPD in MGMGH, Trichy. 
 
Study period: 
 June 2015 to December 2015 
 
Sample size: 
 75 
 
Inclusion Criteria: 
Perimenopausal women with abnormal uterine bleeding between 
40 and 55 years of age. 
 
Exclusion Criteria: 
 Unwilling patients. 
 Large myomas. 
 Premalignant / malignant lessons of cervix, ovary and genitalia. 
 Cervical stenosis. 
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Perimenopausal woman attending gynaecological OPD in MGMGH 
Trichy with abnormal uterine bleeding during the study period were 
included. 
 
Demographic data including age, socioeconomic status and parity 
were collected. The presenting gynaecological complaint with its duration 
and accompanying comorbidities were noted. After detailed history, 
medical examination and gynecological examination done after obtaining 
informed consent. 
 
Imaging and biopsy was done for the entire study population between 
day 1 – 7 in women with history of regular cycles or after bleeding in 
women with history of irregular cycles. Transvaginal sonography was 
done with EMP 40, image point of 7.5M Hz endocavitary probe with 
bladder empty and findings noted. 
 
The TVS probe was then removed and Sims speculum inserted to 
visualize the cervix and to hold the anterior lip of cervix with a vulsellum.   
Cervix was cleaned with povidone iodine and 5F size infant feeding tube 
was introduced into the uterine cavity. 
 
The probe was reintroduced into the vagina, sterile saline of about 
10ml was injected through the tube and the cavity distended. The uterus 
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was scanned in longitudinal axis from one corner to other, then in 
transverse direction from fundus to cervix and findings noted. 
All woman were subjected to fractional curettage under sterile aseptic 
precautions and collected histopathologic specimens were immediately 
placed into a 10% neutral buffered formalin solution and sent for 
histopathologic evaluation and findings noted. Hysterectomy findings, if 
done for conditions like fibroid endometrial hyperplasia, polyps, etc. were 
noted.A final pathologic diagnosis was made by using the results of the 
histopathologic examination and surgical procedure, if any. The 
pathologists were blinded to the TVS and SIS findings.  
 
 Sample size to compare and correlate the imaging modalities with 
each other against the final pathologic diagnosis was calculated to be 40. 
 
 Mean was used to measure the central tendency among parametric 
data like age. Median was used to measure the central tendency among 
non-parametric data like endometrial thickness. Bivariate analysis was 
done to compare endometrial thickness by TVS with SIS. Chi square test 
was used to compare categorical variables. Sensitivity, specificity, 
positive predictive value and negative predictive value was computed for 
imaging diagnostic modalities. All statistical analysis was done using 
SPPS software version 16. 
 
61 
 
RESULTS AND DISCUSSION 
Figure 1. Study flow chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A total of 79 perimenopausal women presented to the gynaecology 
OPD in MGMGH Trichy during the study period with abnormal uterine 
bleeding. 4 patients were excluded as 3 had carcinoma cervix and 1 
patient had a large myoma. Hence 75 women were included in the study, 
TVS, SIS and histopathologic examination done on all of them. 44 among 
the 75 were followed up with hysterectomy findings. 
No. of perimenopausal 
women with AUB during 
study period 
n= 79 
Sample size 
n= 75 
Followed up with 
hysterectomy 
n= 44 
Excluded n= 4 
Carcinoma 
cervix- 3 
Large myoma- 1 
Hysterectomy 
not indicated  
n= 31 
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Table 1. Demographic characteristics of study population 
Demographic characteristic Study population (n=75) 
Age  
40 – 44 years 
45 -  49 years 
>50  years 
Mean ±SD (Range) years 
 
30 (40.0%) 
44 (58.7%) 
1 (1.3%) 
44.64 ± 2.9 (40-52) 
Socioeconomic status 
I 
II 
III 
IV 
V 
 
0 
0 
9   (12.0%) 
23 (30.7%) 
43 (57.3%) 
,,,,,Parity 
1 
2 
3 
4 
5 
7 
 
13 (17.3%) 
30 (40.0%) 
17 (22.7%) 
11 (14.7%) 
3 (4.0%) 
1 (1.3%) 
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Among perimenopausal women, the average at presentation is 
44.64 ± 2.9 years with an age group varying between 40 and 52 years. 
This is similar to the average age at presentation of 46.2 in a study by 
Dasgupta et al
27
.Most women (58.7%) belonged to the age group of 45-49 
years. This is similar to another Indian study by Shobha et al 
32
 where 40 
% of the study population were between 48 and 51 years. 
 
Most of the women belonged to Class Vsocioeconomic status 
(57.3%) according to modified Kuppuswamy scale, with all of them 
within classes III to V. 
 
82.7 % of the study population is multiparous with most being 
diparous (40.0%). In the study by Dasgupta et al
27 
a similar proportion 
(88.5%) were multiparous. The parity of our study population is 
significantly higher than the study population of a similar study in Kerala 
35
.Only 29.5% of their study population had a parity of 3 or more 
compared to 42.7% in our study population.  
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Table 2. Presenting complaints and duration 
Presenting complaint 
 
Median duration (75
th
, 25
th
 
centile) months 
 
N= 75 
 
Intermenstrual bleeding 
 
2.0 (4.3, 0.7) 
4 
(5.3%) 
 
Menorrhagia 
 
8.0 (12.0, 4.0) 
46 
(61.4%) 
 
Polymenorrhea 
 
6.0 (10.0, 6.0) 
9   
(12.0%) 
 
Metropathia 
 
4.5 (10.5, 3.0) 
4 
(5.3%) 
 
Menometrorrhagia 
 
6.0 (11.0, 4.5) 
12 
(16.0%) 
  
 The most common presenting symptom is menorrhagia (61.4%) 
followed by menometrorrhagia (16.0%). This is similar to other studies 
where menorrhagia was the most common presenting complaint ranging 
between 46.5 % to 73% in other studies 
29,32
.Those with menorrhagia 
presented with the complaint for an average duration of 8 months. 
Polymenorrhoea, metropathia and menometrorrhagia presented at an 
average duration between 4.5 to 6 months, those with intermenstrual 
bleeding presented early at an average duration of 2 months since onset of 
symptoms.  
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Table 3. Frequencies of the associated comorbidities 
Comorbid illness Frequency (n=75) 
Anemia 11 (14.7%) 
Hypertension 10 (13.3%) 
Diabetes mellitus 10 (13.3%) 
Overweight 7   (9.3%) 
Hypothyroidism 2   (2.8%) 
Seizure 1   (1.3%) 
Nil 34 (45.3%) 
 
Figure 2. Frequencies of the associated comorbidities 
 
 
Comorbidities 
Anemia Hypertension Diabetes mellitus Hypothyroidism 
Overweight Seizure Nil 
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Most of the women (45.3%), had no associated comorbidity. The 
most common comorbidity seen was anemia (14.7%) followed by 
hypertension and diabetes mellitus in 13.3% each. A high percentage of 
the population was also overweight (9.3%) 
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Table 4. TVS thickness in relation to presenting complaint 
 
Presenting complaint TVS Median (75
th
, 25
th
 centile)  
mm 
Intermenstrual bleeding 4.0 (7.0, 4.0) 
Menorrhagia 8.0 (11.3, 4.0) 
Polymenorrhea 8.0 (16.0, 4.5) 
Metropathia 12.0 (18.0, 7.5) 
Menometrorrhagia 10.0 (13.9, 6.5) 
 
 The average endometrial thickness assessed by TVS is maximum 
(12 mm) when the presenting complaint is metropathia. Those women 
who presented with intermenstrual bleeding had the minimum average 
TVS thickness of 4 mm. The average endometrial thickness was between 
8-10 mm among those presenting with menorrhagia, polymenorrhea and 
menometrorrhagia.  
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Table 5: TVS findings 
Finding N=75 % 
Normal 46 61.3 
Thickened 9 12.0 
Adenomyosis 7 9.3 
Adnexal mass 5 6.7 
Fibroid 5 6.7 
Cervical polyp 2 2.7 
Polyp 1 1.3 
 
Figure 3. TVS findings 
 
TVS findings
Normal Thickened Adenomyosis Adnexal mass 
Fibroid Cervical polyp Polyp
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Most women who underwent TVS for AUB in the perimenopausal 
age group had normal findings. (61.3%). The most common abnormal 
finding seen is a thickened endometrium in 12.0% of the population. 
Adenomyosis (9.3%), Fibroid (6.7%) and adnexal mass (6.7%) were the 
next common diagnosis. Polyps were also rarely picked up by TVS in 
3.8% of the study population.  
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Table 6. HPE findings 
HPE Finding N=75 % 
Proliferative 25 33.3 
Secretory 22 29.3 
Atrophic 10 13.3 
Cystoglandular hyperplasia 7 9.3 
Simple hyperplasia 4 5.3 
Complex hyperplasia without atypia 3 4.0 
Disorderly proliferative 2 2.7 
Complex hyperplasia with atypia 1 1.4 
Adenocarcinoma 1 1.4 
 
Figure 4. HPE findings 
 
 
HPE findings
Proliferative Secretory
Atrophic Cystoglandular hyperplasia
Simple hyperplasia Complex hyperplasia without atypia
Disorderly proliferative Complex hyperplasia with atypia
Adenocarcinoma
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Histopathologic examination was performed on the entire study 
population. One- third (33.3%) of the study population showed 
proliferative phase and almost another one third (29.3%) showed 
secretory phase. Atrophic histopathology was the third most common 
seen in 13.3% of the population. This is similar to Shobha et al
32
 where 
the most common histopathologic finding was proliferative.  
 
Endometrial malignancy is seen in 1.4 % of the population, as 
compared to 4% in other Indian studies 
32
.The reason for a decreased 
incidence compared to the international population is attributed to very 
little use of hormone replacement therapy.  
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Figure 5. Correlation between TVS and endometrial thickness by SIS 
 
 
  
There is a significant linear relation (p value <0.001) between the 
endometrial thickness measured by TVS and SIS with a Pearson correlate 
of +0.82.  
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Table 7. Correlation between HPE finding and endometrial thickness 
by TVS and SIS 
 
HPE Finding 
 
TVS (75
th
,25
th
 
centile) mm 
SIS (75
th
,25
th
centile) 
mm 
Proliferative 8.0 (12.5, 6.0) 8.0 (12.0,5.0) 
Secretory 6.0 (10.0, 5.0) 6.0 (8.5, 6.0) 
Atrophic 4.0 (4.0, 3.0) 3.5 (4.0, 2.0) 
Cystoglandular hyperplasia 11.0 (18.0, 10.0) 14.0 (18.0, 10.0) 
Simple hyperplasia 10.0 (18.0, 8.0) 16.0 (26.0, 9.0) 
Complex hyperplasia 
without atypia 
10.0 (-,9.5) 10.0 (-,10.0) 
Disorderly proliferative 7.5(-,3.0) 5.5 (-,2.0) 
Complex hyperplasia with 
atypia 
14.0(-,-) 16.0(-,-) 
Adenocarcinoma 18.0(-,-) 17.0(-,-) 
  
 The maximum endometrial thickness (TVS- 18 mm, SIS- 17 mm) 
was seen in a woman diagnosed with adenocarcinoma. The average 
endometrial thickness for women with a proliferative histopathology is 8 
mm (both TVS and SIS), which is marginally more than women with a 
secretory histopathology (6 mm- both TVS and SIS) and significantly 
thicker than those with atrophic histopathology (4mm- TVS 3.5 mm- 
SIS).  
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Table 8. Correlation between endometrial thickness by SIS and HPE 
finding 
SIS 
thickness 
n= 
75 
Prl 
n(%) 
Sec 
n(%) 
Atr 
n(%) 
CGH 
n(%) 
SH 
n(%) 
CHWOA 
n(%) 
Dis 
n(%) 
CHWA 
n(%) 
Ade 
n(%) 
0-5 
Mm 
21 
6 
(28.6) 
4 
(19.0) 
10 
(47.6) 
   
1 
(4.8) 
  
6-10 
Mm 
32 
11 
(34.5) 
15 
(46.9) 
 
2 
(6.2) 
1 
(3.1) 
2 
(6.2) 
1 
(3.1) 
  
11-15 mm 12 
7 
(58.3) 
2 
(16.7) 
 
2 
(16.7) 
1 
(8.3) 
    
16-20 mm 8 
1 
(12.5) 
1 
(12.5) 
 
3 
(37.5) 
1 
(12.5) 
  1 (12.5) 
1 
(12.5) 
>20 
Mm 
2     
1 
(50) 
1 
(50) 
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The most common endometrial thickness by SIS was between 6 -
10mm seen in 42.6% of the study population. This is similar to the study 
by Shobha et al 
32
 where 46.5% of the study population had an 
endometrial thickness between 5 and 9.9 mm.  
 
The most common histopathologic finding among women with 
endometrial thickness <5 mm by SIS is atrophic (47.6%), though an equal 
proportion of 47.6% was contribute by secretory and proliferative 
histopathology combined. 
 
 100 % of those with atrophic histopathology had endometrial 
thickness < 5 mm.  
 
 The most common HPE finding in women with endometrial 
thickness between 6-10 mm is secretory (46.9%), closely followed by 
proliferative phase (34.5%).  
Key to Table 8: 
Prl – Proliferative                               CH- Complex hyperplasia 
Sec- Secretory                                    WA- With atypia 
Atr- Atrophic                                      WOA- Without atypia 
CGH- Cystoglandular hyperplasia      Dis- disorderly proliferative 
SH- Simple hyperplasia                      Ade- Adenocarcinoma 
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 This finding is reversed among women with endometrial thickness 
11-15 mm, with 58.3 % showing proliferative HPE compared to 16.7% 
showing secretory HPE. 
 
 Though contributing to two third of the study population, no 
women with proliferative or secretory phase had an endometrial thickness 
> 20mm. Two such women were seen, one having simple hyperplasia and 
the other woman having complex hyperplasia without atypia.  
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Table 9. Correlation between TVS and hysterectomy in diagnosing 
polyp 
 
 
Hysterectomy 
Polyp + 
 
Hysterectomy 
Polyp - 
P value 
(n= 44) 
 
TVS Polyp + 
 
1 0 
0.032(S) 
 
TVS Polyp – 
 
7 36 
 
Sensitivity= 12.5% Specificity= 100% PPV= 100% NPV= 83.7% 
 
 TVS diagnoses polyp with a very low sensitivity of 12.5%, though 
it is 100 % specific with a significant statistical significance. It is found to 
have a high positive predictive value of 100 % and a negative predictive 
value of 83.7%. The sensitivity of TVS in diagnosing polyp varies 
between 25% to 71.4% in other studies 
27,29
. The specificity ranged 
between 95.2% and 97%, PPV being 83% and NPV of 95%.  
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Table 10 Correlation between TVS and hysterectomy in diagnosing 
fibroid 
 
 
Hysterectomy 
Fibroid + 
 
Hysterectomy 
Fibroid - 
P value 
(n=44) 
 
TVS Fibroid + 
 
2 3 
0.011(S) 
 
TVS Fibroid – 
 
3 36 
 
Sensitivity= 40% Specificity= 92.3% PPV= 40% NPV= 92.3% 
 
 
 Though there is a statistical significance (p value- 0,011) TVS has 
a poor sensitivity (40%) and poor positive predictive value of 40% in 
diagnosing fibroid. It however has a better specificity and negative 
predictive value of 92.3% each.  
 
 In other studies 
27,29
, the sensitivity ranged between 65.4% and 
77.3%, specificity between 76% and 97.4%, with a PPV of 70% and NPV 
of 82%. 
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Table 11. Correlation between SIS and hysterectomy in diagnosing 
polyp 
 
 
Hysterectomy 
Polyp + 
 
Hysterectomy 
Polyp - 
P value 
(n=44) 
 
SIS Polyp + 
 
5 0 
<0.001(S) 
 
SIS Polyp – 
 
3 36 
 
Sensitivity= 62.5% Specificity= 100% PPV= 100% NPV= 92.3% 
 
 
 SIS has a sensitivity of 62.5% and specificity of 100% in the 
diagnosis of fibroid. This translates as a PPV of 100% with a negative 
predictive value of 92.3%. 
 
 SIS had improved sensitivity compared to TVS in other studies 
also 
27,29
, ranging between 65.4% and 74%, with a high specificity of 
97%, PPV of 75% and NPV of 91%. 
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Table 12. Correlation between SIS and hysterectomy in diagnosing 
fibroid 
 
 
Hysterectomy 
fibroid + 
 
Hysterectomy 
fibroid - 
P value 
(n=44) 
 
SIS Fibroid + 
 
3 0 
<0.001(S) 
 
SIS Fibroid – 
 
2 39 
 
Sensitivity= 60% Specificity= 100% PPV= 100% NPV= 95.1% 
 
 
 The sensitivity of SIS in diagnosing fibroid is 60% and its 
specificity is 100%. It has a PPV of 100% and NPV of 95.1% 
 
 SIS was more sensitive in diagnosing fibroid also compared to 
TVS. In other studies 
27,29
, the sensitivity ranged between 86.4% and 
85.7%, with a specificity between 93% and 98.7%. The NPV and PPV in 
those studies were both 90%. 
  
81 
 
Table 13. Correlation between TVS and SIS in diagnosing fibroid 
and polyp 
 
 
Imaging findings 
TVS SIS 
 
 
Hysterectomy 
finding 
Polyp 
Sn= 12.5% 
Sp= 100% 
PPV= 100% 
NPV= 83.7% 
pvalue- 0.032 
Sn= 62.5% 
Sp= 100% 
PPV= 100% 
NPV= 92.3% 
pvalue <0.001 
Fibroid 
Sn= 40% 
Sp= 92.3% 
PPV= 40% 
NPV= 92.3% 
pvalue- 0.011 
Sn= 60% 
Sp= 100% 
PPV= 100% 
NPV= 95.1% 
pvalue<0.001 
 
 Both TVS and SIS are significantly correlated with diagnosing 
fibroid and polyp (p value <0.05), however SIS has a more significant 
correlation (p value <0.001).   
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TVS has poor sensitivity in diagnosing polyp (12.5%) against SIS 
(62.5%). SIS also has a higher negative predictive value in diagnosing 
polyp (92.3%) against 83.7% by TVS. Both are equally specific (100%) 
and have a 100% positive predictive value. 
 
In diagnosing fibroid, SIS is found to be a more useful diagnostic 
tool when compared to TVS with a higher sensitivity (60% vs 40%), 
specificity (100% vs 92.3), higher positive predictive value (100% vs 
40%) and a higher negative predictive value (95.1% vs 92.3%). 
 
This result of SIS being superior to TVS is validated by other 
studies also 
27,29.
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Table 14: Complications of SIS 
Complications No. of patients Percentage 
Post procedure pain 4 5.2% 
No complication 71 94.8% 
 
Among the 75 women enrolled, 4 women (5.2%) experienced post- 
procedure pain during SIS requiring analgesics. This is comparable to 
current studies 
29
and is significantly less than in study by Cincenni et al 
31
done two decades back.  
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SUMMARY 
 
1. Among perimenopausal women with abnormal uterine bleeding, 
the mean age at presentation is 44.64 ± 2.9 years. 
 
2. Most perimenopausal women with abnormal uterine bleeding 
(82.7%) are multiparous with 42.7% of them being triparous or 
more. 
 
3. The most common presenting symptom among perimenopausal 
women with abnormal uterine bleeding is menorrhagia (61.4%) 
and the average duration of menorrhagia is 8 months at 
presentation.  
 
4. Most of the perimenopausal women with abnormal uterine 
bleeding (45.3%) have no associated comorbidity. The most 
common comorbidity seen is Anemia (14.7%). 
 
5. The average endometrial thickness of perimenopausal women 
presenting with abnormal uterine bleeding assessed by TVS varies 
between 4 to 12 mm, being the lowest (average 4mm) when 
intermenstrual bleeding is the presenting complaint and highest 
(average 12 mm) when the presenting symptom is metropathia. 
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6. The TVS among perimenopausal women presenting with abnormal 
uterine bleeding is mostly normal (61.3%). Apart from a thickened 
endometrium (12.0%), the most common TVS finding is 
adenomyosis (9.3%). 
7. The most common finding in perimenopausal women presenting 
with abnormal uterine bleeding is proliferative histopathology 
(33.3%), closely followed by secretory histopathology (29.3%). 
 
8. There is a significant linear relation (p value <0.001) between the 
endometrial thickness measured by TVS and SIS with a Pearson 
correlate of +0.82.  
 
9. The average endometrial thickness for women with a proliferative 
histopathology is 8 mm (both TVS and SIS), which is marginally 
thicker than women with a secretory histopathology (average 6 
mm- both TVS and SIS) and significantly thicker than those with 
atrophic histopathology (average 4mm- TVS 3.5 mm- SIS).  
 
10. The most common endometrial thickness by SIS in 
perimenopausal women with abnormal uterine bleeding is between 
6 -10mm seen in 42.6% of the study population. 
 
11. The most common histopathologic finding among women with 
endometrial thickness <5 mm by SIS is atrophic (47.6%). All 
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women with atrophic histopathology had endometrial thickness < 5 
mm. 
 
12. The most common histopathologic finding is secretory (46.9%), 
among women with endometrial thickness between 6-10 mm by 
SIS and proliferative (58.3%) among those with endometrial 
thickness between 11-15 mm by SIS. No women with proliferative 
or secretory histopathology had an endometrial thickness > 20mm. 
13. In diagnosing polyp, TVS has a very low sensitivity of 12.5%, 
though it has 100 % specificity with a positive predictive value of 
100 % and a negative predictive value of 83.7%. In diagnosing 
fibroid, TVS has a low sensitivity (40%), specificity of 92.3%, and 
a low positive predictive value of 40% and a negative predictive 
value of 92.3% each. 
 
14. In diagnosing polyp, SIS has a sensitivity of 62.5% and specificity 
of 100% with a positive predictive value of 100% and a negative 
predictive value of 92.3%. In diagnosing fibroid, SIS has a 
sensitivity of 60%, specificity of 100%, and positive predictive 
value of 100% and negative predictive value of 95.1%. 
 
15. In diagnosing polyp, SIS has a higher sensitivity (62.5%) 
compared to TVS (12.5%). SIS also has a higher negative 
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predictive value (92.3%) compared to TVS (83.7%). Both have 
equal specificity (100%) and equal positive predictive value 
(100%). 
 
16. In diagnosing fibroid, SIS has a higher sensitivity (60%) compared 
to TVS (40%), higher specificity (100%) compared to TVS 
(92.3%), a higher positive predictive value (100%) compared to 
TVS (40%) and also a higher negative predictive value (95.1%) 
compared to TVS (92.3%). 
  
17. During SIS, 5.2% of women experienced post- procedure pain 
requiring analgesics. 
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CONCLUSION 
 
Among perimenopausal women with abnormal uterine bleeding, 
the most common presenting symptom is menorrhagia seen in 61.4% of 
the study population. 
 
Among perimenopausal women with abnormal uterine bleeding, 
TVS is mostly normal (61.3%). Other common findings are thickened 
endometrium (12.0%) and adenomyosis (9.3%). 
 
 
The most common histopathological finding in perimenopausal 
women with abnormal uterine bleeding is proliferative histopathology 
(33.3%) followed by secretory histopathology (29.3%). 
 
 
The endometrial thickness as measured by SIS correlates with 
histopathological examination as follows: 
SIS Thickness 
 
Most common histopathological 
finding 
 
< 5 mm 
 
Atrophic (47.6%) 
 
6-10 mm 
 
Secretory (46.9%) 
 
11-15 mm 
 
Proliferative (58.3%) 
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SIS is a better diagnostic tool in diagnosing fibroid and polyp 
compared to TVS with a minimal procedural complication rate. 
 
In diagnosing polyp, SIS has a higher sensitivity and higher negative 
predictive value compared to TVS. 
   
In diagnosing fibroid, SIS has higher sensitivity, specificity, positive 
predictive value and negative predictive value compared to TVS. \ 
 
Only 5.2% of women experienced post- procedure pain following SIS.  
 
  
90 
 
BIBLIOGRAPHY 
                                                          
 
1. Soules MR, Sherman S, Parott E. Stages of reproductive aging 
workshop (STRAW). J. Womens Health, Gender Based Med. 2001 
; 10 : 843-8 
2. Awwad JT, Toth TL, Schiff I .Abnormal uterine bleeding in the 
perimenopause .Int J Fertil .and Menopausal Stud . 
1993;38(5);261-9 
3. Schorge , John O , Williams , J . whitridge , Williams gynecology , 
pg 175 , The Mc graw Hill companies , china ,press , 2008 
4. FIGO classification system (PALM – COEIN) for the causes of 
abnormal uterine bleeding in non gravid women of reproductive 
age. International Journal of Gynecology and Obstetrics 2011 ; 
113 : 3 - 13 
5. Epstein E, Ramirez A, Skoog L, Valentin L. Transvaginal 
sonography , saline contrast sonohysterography and hysteroscopy 
for the investigation of women with postmenopausal bleeding and 
endometrium > 5 mm . Ultrasound Obstet Gynecol. 2001 ; 18 : 157 
- 62 
6. Balakrishnan,shiela , Textbook of Gynecology , 2nd ed pg.24 , 
paras medical publisher 2016 , Hyderabad , print . 
91 
 
                                                                                                                                                                      
7. Nikolics K, Mason AJ, Szonyi E, Ramachandran J, Seeburg PH, A 
prolactin-inhibiting factor within the precursor for human 
gonadotropin-releasing hormone, Nature 316:511, 1985. 
 
8. Yong EL, Baird DT, Hillier SG, Mediation of 
gonadotropinstimulated growth and differentiation of human 
granulosa cells by adenosine-3', 5'-monophosphate: one molecule, 
two messages, Clin Endocrinol 37:51, 1992. 37.  
9. Eppig JJ, Chesnel F, Hirao Y, O‟Brien MJ, Pendola FL, Watanabe 
S, Wigglesworth K, Oocyte control of granulosa cell development: 
how and why, Hum Reprod 12(Suppl):127, 1997. 
10. Liu JH, Yen SSC, Induction of midcycle gonadotropin surge by 
ovarian steroids in women: a critical evaluation, J Clin Endocrinol 
Metab 57:797, 1983. 
11. Girsh E, Milvae RA, Wang W, Meidan R, Effect of endothelin-1 
on bovine luteal cell function: role in prostaglandin F2a-induced 
antisteroidogenic action, Endocrinology 137:1306, 1996.s 
12. Berek JS , Adashi EY , Hillard PA (eds ) Novak‟s gynecology 15 
th edition , chapter 7 reproductive physiology g 149 
13. Ferenczy A , Bertrand G , Gelfand MM .proliferation kinetics of 
human endometrium during normal menstrual cycle Am J Obstet 
gynecol 1979 ; 133 : 859 - 867 
92 
 
                                                                                                                                                                      
14. Noyes RW, Hertig AW, Rock J. Dating of the endometrial biopsy 
.Fertil Steril 1950 ; 1 : 3 - 25 
15. Parsons AK, Lense JJ. Sonohysterography for endometrial 
abnormalities: preliminary results .J Clin Ultrasound. 1993 ; 21 87 
- 95 
16. DL Berridge, TC Winter - Journal of ultrasound in medicine, 2004 
- Am Inst Ultrasound Med 
17. Tur – kaspa I , Gal M , Hartmann M et al . A prospective 
evaluation of uterine abnormalities by saline infusion 
sonohysterography in 1009 women with infertility or abnormal 
uterine bleeding Fertil Steril 2006 ; 86 : 1731 – 1735 
18. Moghadam R, Lathi RB, Shamohamady B et al. predictive value of 
magnetic resonance imaging in differentiating between leiomyoma 
and adenomyosis JSLS 2006 ;10 : 216 - 219 
19. Allameh T, Mohammadizadeh F. Diagnostic value of hysteroscopy 
in abnormal uterine bleeding compared to pathology reports. 
Iranian J Reprod Med 2007 ; 5 : 61 - 4 
20. Bettochi S  , Ceci O , Vinico M , marello F , Impedovo L , 
Selvaggi L . Diagnostic inadequacy of dilatation and curettage. 
Fertil Steril .2001 ; 75 : 803 – 5  
93 
 
                                                                                                                                                                      
21. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial 
hyperplasia: long term study of “untreated” hyperplasia in 170 
patients. Cancer 1985;56: 403 – 412. 
22. Vosse M, Renard F, Coibion M, Neven P, Nogaret JM, Hertens D. 
Endometrial disorders in 406 breast cancer patients on tamoxifen: 
the case for less intensive monitoring. Eur J Obstet Gynecol 
Reprod Biol 2002; 101:58–63. 
23. Seshadri Lakshmi, Essentials of gynecology, 1st ed. Pg .105 – 107 , 
Wolters Kluwer Ind Pvt Ltd., New Delhi 2011 , print. 
24. Ferenczy A, Pathophysiology of endometrial bleeding, Maturitas 
45:1, 2003 
25. Clinical gynecologic endocrinology and infertility eighth edition 
Leon Speroff and Marc A fritz chapter 15 page 600.   
26. Schorge , John O , Williams , J . whitridge , Williams gynecology , 
pg 185 , The Mc graw Hill companies , china ,press , 2008 
27. Dasgupta Subhankar , The journal of obstetrics and gynecology of 
India March / April 2011 pg. 189 – 194 
28. Mathew M , Gupta R , Krolikouski  A .Role of transvaginal 
ultrasonography and diagnostic hysteroscopy in the evaluation of 
patients with Abnormal uterine bleeding Int J Gynaecol Obstet 
2000 ; 71 : 251 – 3 
94 
 
                                                                                                                                                                      
29. Reddi Rani P, J Obstet Gynecol India Vol. 60,No. 6 : Nov / Dec 
2010 page  511 – 515 
30. Saidi MH , Sadler RK ,Theis VD et al , comparison of sonography 
, sonohysterography and hysteroscopy for evaluation of abnormal 
uterine bleeding .J ultrasound Med 1997 : 16; 587 – 91 
31. Cicineli E , Romano F , Anastasio PS et al , Transabdominal 
sonohysterography , transvaginal sonography and hysteroscopy in 
the evaluation of submucous myomas .Obstet Gynecol 1995 : 85 ; 
42 – 7 
32. Shobha S Pillai . International journal of Reproduction  , 
contraception , Obstetrics and Gynecology Pillai SS 2014 Mar ; 3 
(1) : 113 - 117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
95 
 
                                                                                                                                                                      
PROTOCOL (DETAILED DESCRIPTION ) 
PROFORMA  
 
NAME  :      IP NO : 
AGE   :      WARD  : 
HEIGHT :      WEIGHT : 
LMP  :  
  
PARA   LIVE   DEATH   ABORTION  
 
FAMILY HISTORY   : 
PRESENTING COMPLAINTS  : 
DURATION OF SYMPTOMS   : 
PAST HISTORY    :  
INVESTIGATION   : 
HB G%     : 
PLATELETS     : 
UREA      : 
CREATININE     : 
SUGAR     : 
CHEST  X RAY     
BLEEDING TIME    :  
CLOTTING TIME    : 
 
TRANSVAGINAL FINDINGS  
 
 
HPE REPORTS  
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SALINE INFUSION HYSTEROGRAM  
Polyp Cyst 
Submucous 
Myoma 
Ca 
growth 
Intramural 
fibroid 
distorting 
Cavity 
Others 
 
 
     
 
 
HYSTERECTOMY  SPECIMEN 
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Nehahspapd; rk;kjf; fbjk; 
 
Ma;T nra;ag;gLk; jiyg;G : 
 khjtplha; tw;Wjy; fhyj;jpy; mjpf cjpug;Nghf;F 
Vw;gLgth;fspd; Cnlhyp kw;Wk; Ez;jpR ghpNrhjidia 
njhlh;Gg;gLj;Jjy;. 
 
Muha;r;rp epiyak; : 
 kfhj;kh fhe;jp muR kUj;Jtkid> jpUr;rp. 
 
gq;F ngWgthpd; ngah; : 
 NkNy Fwpg;gplg;gl;Ls;s kUj;Jt Ma;tpd; tptuq;fs; vdf;F 
tpsf;fg;gl;lJ. vd;Dila khjtplha; fhyj;jpy; Vw;gLk; gpd; 
tpisTfisAk; mjd; Kf;fpaj;Jtj;ijAk; kUj;Jthpd; %yk; 
mwpe;J nfhz;Nld;. Nkw;nfhz;l Ma;tpy; vd;id <LgLj;jp 
mjw;fhd rpfpr;iriaAk; ,e;j Ma;tpd; %yk; fpilf;Fk; vd;gijAk; 
mwpe;J ,e;j Ma;Tf;F KOkdJld; gq;Nfw;f rk;kjpf;fpd;Nwd;. 
 
 midj;J kUj;Jtkidfspy; ,Ug;gJ NghyNt ,k;kUj;Jt 
KiwapYk; vjph;ghuh ,lh;fs; Nehplyhk;.  cq;fs; kUj;Jt 
gjpNtLfs; kpfTk; me;juq;fkhf itj;Jf; nfhs;sg;gLk;. ,e;j 
Ma;tpd; KbTfs; gj;jphpf;iffspy; gpuRhpf;fg;glyhk;. Mdhy; cq;fs; 
ufrpaj; jd;ik ghJfhf;fg;gLk;.  ,e;j Ma;tpypUe;J jhq;fs; ve;j 
NeuKk; fhuzkpy;yhky; tpyfpf; nfhs;syhk;.  vg;gbapUe;jhYk; 
Njitahd rpfpr;ir mspf;fg;gLk;.  ,ij mwpe;J jd;dpr;irahf 
,e;j Ma;tpy; gq;Nfw;fpNwd;. 
 
 ,e;j Ma;T rk;ke;jkhfNth ,ij rhh;e;J NkYk; 
Nkw;nfhs;Sk; kw;w Ma;Tfspy; gq;Nfw;Fk; kUj;Jth; vd; kUj;Jt 
mwpf;iffis ghh;g;gjw;F vd; mDkjp Njitapy;iy vd;gij 
mwpNtd;.  vdJ eyd; fUjpNa ,e;j Ma;T Nkw;nfhs;sg;gLfpwJ 
vd;W njhpe;J ,e;j Ma;tpw;F rk;kjpf;fpNwd;.  
            
ifnahg;gk; 
           my;yJ 
         ,lJ fl;iltpuy; ifehl;il 
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Nehahspapd; jfty; jhs; 
 
 khjtplha; tw;Wjy; fhyj;jpy; mjpf cjpug;Nghf;F 
Vw;gLgth;fspd; Cnlhyp kw;Wk; Ez;jpR ghpNrhjidia 
njhlh;Gg;gLj;Jjy;. 
 
 Nkw;nfhz;l Ma;tpy; vd;id <LgLj;jp mjw;fhd 
rpfpr;iriaAk; ,e;j Ma;T %yk; fpilf;Fk; vd;gijAk; mwpe;J 
,e;j Ma;tpy; KOkdJld; gq;Nfw;f rk;kjpf;fpNwd;. 
 
 midj;J kUj;Jtkidfspy; ,Ug;gJ NghyNt ,k;kUj;Jt 
KiwapYk; vjph;ghuh ,lh;fs; Nehplyhk;. cq;fs; kUj;Jt 
gjpNtLfs; kpfTk; me;juq;fkhf itj;Jf; nfhs;sg;gLk;. ,e;j 
Ma;tpd; KbTfs; gj;jphpf;iffspy; gpuRhpf;fg;glyhk;. Mdhy; cq;fs; 
ufrpaj; jd;ik ghJfhf;fg;gLk;. ,e;j Ma;tpypUe;J jhq;fs; ve;j 
NeuKk; fhuzkpy;yhky; tpyfpf; nfhs;syhk;. vg;gbapUe;jhYk; 
Njitahd rpfpr;ir mspf;fg;gLk;. ,ij mwpe;J jd;dpr;irahf ,e;j 
Ma;tpy; gq;Nfw;fpNwd;. 
 
 ,e;j Ma;T rk;ke;jkhfNth ,ij rhh;e;J NkYk; 
Nkw;nfhs;Sk; kw;w Ma;Tfspy; gq;Nfw;Fk; kUj;Jth; vd; kUj;Jt 
mwpf;iffis ghh;g;gjw;F vd; mDkjp Njitapy;iy vd;gij 
mwpNtd;. vdJ eyd; fUjpNa ,e;j Ma;T Nkw;nfhs;sg;gLfpwJ 
vd;W njhpe;J ,e;j Ma;tpw;F rk;kjpf;fpNwd;. 
 
 
 
 ifnahg;gk; 
           my;yJ 
         ,lJ fl;iltpuy; ifehl;il 
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